Factores asociados a ingreso a UCI en pacientes con IRAG por SARS CoV-2 durante la pandemia en hospitales colombianos

dc.contributor.advisorCortés Luna, Jorge Alberto
dc.contributor.authorOrtega Quintero, Adriana Paola
dc.contributor.datacollectorGómez Rodriguez Rosario
dc.contributor.datacollectorSánchez González Sandra
dc.contributor.researcherVillalobos Díaz Maxi Fayibe
dc.contributor.researcherMorantes Caballero Jairo Alberto
dc.coverage.countryColombia
dc.date.accessioned2023-02-07T13:31:02Z
dc.date.available2023-02-07T13:31:02Z
dc.date.issued2023-02-03
dc.descriptionilustraciones, gráficas, tablasspa
dc.description.abstractIntroducción: Los pacientes con COVID-19 presentan un espectro clínico variable y su severidad está influenciada por factores de riesgo individuales. Identificarlos de manera oportuna permite predecir formas graves de la enfermedad. Objetivo: Determinar los factores asociados al ingreso a unidad de cuidados intensivos (UCI) en pacientes hospitalizados por COVID-19 durante las primeras 2 olas de la epidemia en Colombia. Materiales y métodos: Estudio de cohorte multicéntrico, retrospectivo en pacientes hospitalizados por COVID-19 en instituciones prestadoras de salud de Bogotá y Girardot, Colombia. Se incluyeron adultos con diagnóstico confirmado de marzo de 2020 a enero de 2021. Se describieron las características sociodemográficas clínicas y paraclínicas de la población y se establecieron las variables independientes que predecían el ingreso a la UCI mediante un modelo de regresión logística multivariada. Resultados: Se incluyeron 1160 pacientes con una edad media de 55 años, 59.7% fueron hombres y 426 pacientes (37.7%) ingresaron a UCI. Los factores asociados a ingreso a UCI fueron edad (OR 1,25, 95%IC: 1,14-1,37 por cada década de vida), sobrepeso (OR 2,82, 95%IC: 1,98-4,02) y obesidad (OR 2,97, 95%IC: 2,03-4,37), antecedente cardiovascular valvular (OR 6,46, 95%IC: 1,84-27,48) hipotensión (OR 2,35, 95%IC: 1,40-3,97), presencia de SIRS (OR 2,03, 95%IC: 1,50-2,74), disnea (OR 1,52, 95%IC:1,09-2.14), requerimiento de oxígeno (OR 2,64, 95%IC: 1,67-4,30 por cada incremento 1% de FiO2), neutrofilia (OR 1,09, 95%IC: 1,05-1,13 por cada 1000 cel/ml), elevación del dímero D (OR: 1,09, 95%IC: 1,03-1,18 por cada 1000 ng/ml), compromiso multilobar (OR 2,19, 95%IC: 1,58-3,07) y consolidación pulmonar (OR 1,52, 95%IC: 1,13-2,04). La mortalidad intrahospitalaria fue de 14,4% (166 pacientes). Conclusión: En esta cohorte de pacientes hospitalizados por COVID-19, el 36,72% ingresaron a UCI, encontrando como principales predictores la edad, obesidad, antecedente de valvulopatía, hipotensión, presencia de SIRS y compromiso pulmonar multilobar. (Texto tomado de la fuente)spa
dc.description.abstractBackground: Patients with COVID-19 present a variable clinical spectrum and its severity is influenced by the presence of risk factors. Identifying them in a timely manner makes it possible to predict severe forms of the disease. Aim: To determine the factors associated with ICU admission in patients hospitalized for COVID-19 during the first 2 waves of the epidemic in Colombia Material and method: Retrospective multicenter cohort study in patients hospitalized for COVID-19 in health care institutions in Bogotá and Girardot, Colombia. Adults with a confirmed diagnosis from March 2020 to January 2021 were included. The clinical and paraclinical sociodemographic characteristics of the population were described and the independent variables that predicted admission to the ICU were obtained using a multivariate logistic regression model. Results: 1160 patients were included: mean age was 55 years, 59,7% were men, and 436 patients (36,7%) were admitted to the ICU. The factors associated with admission to the ICU were age (OR 1,25, 95%CI: 1,14-1,37 for each decade of life), overweight (OR 2,82, 95%CI: 1,98-4,02) and obesity (OR 2,97, 95%CI: 2,03-4,37), antecedent valvular cardiovascular disease (OR 6.46, 95%CI: 1.84-27.48), hypotension (OR 2,35, 95%CI: 1,40-3,97), presence of SIRS (OR 2,03, 95%CI: 1,50-2,74), dyspnea (OR 1,52, 95%CI: 1,09-2,14), oxygen requirement (OR 2,64, 95%CI: 1,67-4,30 for each 1% increase in FiO2), neutrophilia (OR 1,09, 95%CI: 1,05-1,13 for each 1000 cells/ml), elevated D-dimer (OR 1,09, 95%CI: 1,03 - 1,18 per 1000 ng/ml) multilobar involvement (OR 2,19, 95%CI: 1,58-3,07) and pulmonary consolidation (OR 1,52, 95%CI: 1,13-2,04). In-hospital mortality was 14,4% (166 patients). Conclusion: In this cohort of patients hospitalized for COVID-19, 36,72% were admitted to the ICU, finding age, obesity, a history of valve disease, hypotension, presence of SIRS, and multilobar pulmonary involvement as the main predictors.eng
dc.description.degreelevelEspecialidades Médicasspa
dc.description.degreenameEspecialista en Medicina Internaspa
dc.description.methodsEstudio epidemiológico, observacional, de cohorte analítico retrospectivo, multicéntrico, en pacientes adultos con diagnóstico confirmado de infección por covid19 que cumplan con los criterios de IRAG establecidos por el Ministerio de Salud según su última revisión (agosto 2010); hospitalizados en instituciones de salud de Bogotá y Girardot - Colombia de marzo de 2020 a enero de 2021. Se describieron las características sociodemográficas clínicas y paraclínicas de la población y se establecieron las variables independientes que predecían el ingreso a la UCI mediante un modelo de regresión logística multivariada.spa
dc.description.researchareaInfectologíaspa
dc.format.extent63 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameUniversidad Nacional de Colombiaspa
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombiaspa
dc.identifier.repourlhttps://repositorio.unal.edu.co/spa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/83346
dc.language.isospaspa
dc.publisherUniversidad Nacional de Colombiaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.placeBogotá, Colombiaspa
dc.publisher.programBogotá - Medicina - Especialidad en Medicina Internaspa
dc.relation.referencesInstituto Nacional de Salud. Protocolo de Vigilancia en Salud Pública - Infección Respiratoria Aguda (IRA). 2018. https://www.ins.gov.co/BibliotecaDigital/PRO-Infección-respiratoria-agudaspa
dc.relation.referencesZhu N, Zhang D, Wang W, Li X, Yang Bo, Song J et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-733spa
dc.relation.referencesCucinotta D, Vanelli M. WHO declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157-160spa
dc.relation.referencesWu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72314 Cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239-1242spa
dc.relation.referencesBhargava A, Fukushima E, Levine M, Zhao W, Tanveer F, Szpunar S et al. Predictors for Severe COVID-19 Infection. Clin infect Dis. 2020;71(8):1962-1968spa
dc.relation.referencesZhou F, Yu T, Ronghui D, Fan G, Liu Y, Liu Z et al, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1962spa
dc.relation.referencesZhang J, Yu Miao, Tong Song, Liu LY, Tang LV. Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China. J Clin Virol. 2020;127:104392spa
dc.relation.referencesWang D, Hu B, Hu C. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069spa
dc.relation.referencesLiu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032-1038spa
dc.relation.referencesBergman J, Ballin M, Nordström A, Nordström P. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Eur J Epidemiol. 2021;36(3):287–298spa
dc.relation.referencesPetrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;m1966spa
dc.relation.referencesMurthy S, Archambault PM, Atique A, Carrier FM, Cheng MP, Codan C, et al. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study. CMAJ Open. 2021;9(1):E181–8spa
dc.relation.referencesZhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273spa
dc.relation.referencesEurosurveillance Editorial Team. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro. Surveill. 2020;25(5):200131espa
dc.relation.referencesCoronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536-544spa
dc.relation.referencesFisher D, Heymann, D. Q&A: the novel coronavirus outbreak causing COVID-19. BMC Med. 2020;18(1):57spa
dc.relation.referencesJin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, et al. Virology, epidemiology, pathogenesis, and control of covid-19. Viruses. 2020;12(4):1–17spa
dc.relation.referencesChan JF, Kok KH, Zhu Z, Chu H, To K, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020;9(1):221-236spa
dc.relation.referencesWang C, Horby P, Hayden F, Gao G. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470-473spa
dc.relation.referencesHolmes E, Goldstein S, Rasmusen A, Robertson D, Christoph A, Wertheim J, et al. The origins of SARS CoV 2: A critical Review. Cell 2021;184(19):4848-4856spa
dc.relation.referencesDeslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Zahar JR, Brichler, et al. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents. 2020;55(6):106006spa
dc.relation.referencesLotfi M, Rezaei N. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. 2020;92(10):1864-1874spa
dc.relation.referencesHu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141-154spa
dc.relation.referencesKing AM, Adams MJ, Carstens EB, Lefkowitz EJ (eds). Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier Inc. 2012; 223–228spa
dc.relation.referencesFan Y, Zhao K, Shi ZL, Zhou P. Bat Coronaviruses in China. Viruses. 2019;11(3):210spa
dc.relation.referencesHe F, Deng Y, Li W. Coronavirus disease 2019: What we know?. J Med Virol. 2020;92(7):719-725spa
dc.relation.referencesRuan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-848spa
dc.relation.referencesEastin C, Eastin T. Clinical Characteristics of Coronavirus Disease 2019 in China: Guan W, Ni Z, Hu Y, et al. N Engl J Med. 2020. J Emerg Med. 2020;58(4):711-712spa
dc.relation.referencesSaavedra Trujillo CH. Resumen: Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud - Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24:3 (S1):1-153spa
dc.relation.referencesMinisterio de salud y protección social de Colombia. Lineamientos para el uso de pruebas diagnósticas de sars-cov-2 (Covid-19) en Colombia ministerio de salud y protección social Bogotá. Agosto de 2022. 2022:1–23spa
dc.relation.referencesGarrow, J.S, Webster, J. Quetelet’s index (W/H2) as a measure of fatness. Int.J.Obes.1985: 9(2):147–153spa
dc.relation.referencesARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012 Jun 20; 307(23):2526–2533spa
dc.relation.referencesSinger M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016 Feb 23; 315(8): 801–810spa
dc.relation.referencesKonstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603spa
dc.relation.referencesCastro MC, Gurzenda S, Macário EM, França GVA. Characteristics, outcomes and risk factors for mortality of 522 167 patients hospitalised with COVID-19 in Brazil: a retrospective cohort study. BMJ Open. 2021; 11(5): e049089spa
dc.relation.referencesSalje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, et al. Estimating the burden of SARS-CoV- 2 in France. Science. 2020; 369 (6500):208–211spa
dc.relation.referencesGrasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323(16):1545-1546spa
dc.relation.referencesGraselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581spa
dc.relation.referencesSifuentes-Osorio J, Angulo-Guerrero O, De Anda-Jáuregui G, Díaz-De-León-Santiago JL, Hernández-Lemus E, Benítez-Pérez H et al. Probability of hospitalisation and death among COVID-19 patients with comorbidity during outbreaks occurring in Mexico City. J Glob Health. 2022;12:05038spa
dc.relation.referencesZeiser F, Donida B, da Costa CA, Ramos GO, Scherer JN, Barcellos NT, et al. First and second COVID-19 waves in Brazil: A crosssectional study of patients’ characteristics related to hospitalization and in-hospital mortality. Lancet Reg Health Am. 2022;6:100107spa
dc.relation.referencesHenríquez A, Accini J, Baquero H, Molina F, Rey A, Ángel VE, et al. Clinical features and prognostic factors of adults with COVID-19 admitted to intensive care units in Colombia: A multicentre retrospective study during the first wave of the pandemic. Acta Colombiana de Cuidado Intensivo. 2022;22(2):95–9spa
dc.relation.referencesIzcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020;15(11): e0241955spa
dc.relation.referencesBooth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, et al. Population risk factors for severe disease and mortality in COVID- 19: A global systematic review and meta-analysis. PLoS ONE. 2021;16(3):e0247461spa
dc.relation.referencesDocherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985spa
dc.relation.referencesHang W, Tipih T, Makoah N, Vermeulen J, Goedhals D, Sempa J, et al. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. mBio. 2021; 12(1): e03647-20spa
dc.relation.referencesYu W, Rohli K, Yang S, Jia P. Impact of obesity on Covid19 patients. J Diabetes Complications. 202;35(3):107817spa
dc.relation.referencesLofti M, Rezai N. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. 2020; 92(10): 1864-1874spa
dc.relation.referencesWang JG, Hur J, Hong KS, Lee W, Ahn JH. Prognostic accuracy of the SIRS, qSOFA, and NEWS for early detection of clinical deterioration in SARS-CoV-2 infected patients. J Korean Med Sci. 2020; 35(25): e234spa
dc.relation.referencesBorges L, Pithon T, Curi R, Hatanaka E. COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps. Mediators Inflamm. 2020; 2020:8829674.spa
dc.relation.referencesYao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8:49spa
dc.relation.referencesSieswerda E, de Boer M, Bonten M, Boersman W, Jonkers R, Aleva R et al. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Clin Microbiol Infect. 2021;27(1):61-66spa
dc.relation.referencesDu Y, Tu L, Zhu P, Mu M, Wang R, Yang P et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med. 2020; 201(11):1372-1379spa
dc.relation.referencesLangford B, So M, Raybardhan S, Leung V, Westwood D, MacFadden D et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020; 26(12):1622-1629spa
dc.rightsDerechos reservados al autor, 2023spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseReconocimiento 4.0 Internacionalspa
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/spa
dc.subject.ddc610 - Medicina y salud::616 - Enfermedadesspa
dc.subject.decsSARS-CoV-2eng
dc.subject.decsSíndrome Respiratorio Agudo Gravespa
dc.subject.decsMedidas de Asociación, Exposición, Riesgo o Desenlacespa
dc.subject.decsMeasures of Association, Exposure, Risk or Outcomeeng
dc.subject.proposalFactores de riesgospa
dc.subject.proposalUCIspa
dc.subject.proposalRisk factorseng
dc.subject.proposalCOVID 19eng
dc.subject.proposalIntensive Care Uniteng
dc.titleFactores asociados a ingreso a UCI en pacientes con IRAG por SARS CoV-2 durante la pandemia en hospitales colombianosspa
dc.title.translatedFactors associated with ICU admission in patients with SARS CoV-2 during the pandemic in Colombian hospitalseng
dc.typeTrabajo de grado - Especialidad Médicaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dcterms.audience.professionaldevelopmentInvestigadoresspa
dcterms.audience.professionaldevelopmentPúblico generalspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
1098742304.2023.pdf
Tamaño:
674.79 KB
Formato:
Adobe Portable Document Format
Descripción:
Trabajo de grado de Especialidad en Medicina Interna

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
5.74 KB
Formato:
Item-specific license agreed upon to submission
Descripción: